Genelex logo — Genelex has been a leader in molecular diagnostics and genet...

Genelex

Genelex has been a leader in molecular diagnostics and genetic testing for more than 30 years.

Founded 1987 United States Seattle, United States 22 employees Biotechnology

General Information

Company Name Genelex
Founded Year 1987
Location United States Seattle, United States +1
Employees 22
Industries Biotechnology
Social

Get notified when Genelex moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Genelex

Genelex has been a leader in molecular diagnostics and genetic testing for more than 30 years. Founded in 1987, Genelex is a highly accredited leader in precision medication management and one of the first clinical laboratories to provide pharmacogenetic testing and interpretation as the creator of YouScript - a patented, proprietary, and powerful clinical decision support tool. More than 90% of the population have genetic variations that determine how their bodies process drugs, including prescription and over-the-counter medications, leading to diverse responses to the same medication dosage. Annually, the United States witnesses 8.6 million dangerous adverse drug events, causing over 100,000 deaths, with the FDA estimating the cost at a minimum of $30 billion per year. Genelex's expert staff and state-of-the-art laboratory are focused on preventing drug-gene and drug-drug interactions, especially in patients with significant polypharmacy who are at most risk. As one of the longest-running leaders in pharmacogenetics, Genelex is committed to helping polypharmacy patients and physicians improve medication outcomes with pharmacogenetic testing. The company offers both clinical and research-level PGx testing to CROs and pharmaceutical companies to ensure safer drugs to market. Genelex envisions making pharmacogenetics a commonplace term in every physician's office and kitchen table across the United States.

Taxonomy: molecular diagnostics, genetic testing, precision medication management, pharmacogenetic testing, clinical decision support tool, drug-gene interactions, drug-drug interactions, polypharmacy management, pharmaceutical research, precision prescribing, DNA testing, adverse drug event prevention, pharmacogenetics, clinical trials, drug sensitivity testing

No funding data available for Genelex yet.

Get notified when Genelex raises funding

Genelex Alternatives & Competitors

Genelex vs

Delivering genetic medication metabolism reports

5 employees
Biotechnology
Genelex vs
Lifetime Sciences
Lifetime Sciences United States

Lifetime Sciences is a CAP accredited and CLIA-certified lab focused on molecular and advanced diagn...

19 employees
Biotechnology, Life Sciences
Genelex vs

Providing genetic and molecular diagnostic solutions to advance healthcare.

5 employees
Health Care

FAQ About Genelex

Genelex has been a leader in molecular diagnostics and genetic testing for more than 30 years.
Genelex was founded in 1987.
Genelex is headquartered in Seattle, United States.
Genelex operates in the following industries: Biotechnology.
Genelex has approximately 22 employees.
Top alternatives and competitors to Genelex include Advanced Genetics Lab, Lifetime Sciences, RESOLVE MOLECULAR DIAGNOSTICS LLC, MD Labs, YouScript. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Genelex and Advanced Genetics Lab are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Genelex and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes